Nektar Therapeutics (NKTR) Capital Leases (2010 - 2017)
Nektar Therapeutics (NKTR) posted quarterly Capital Leases of $1.1 million for Q2 2017, down 61.68% year-over-year from $2.8 million in Q2 2016, and down 34.37% quarter-over-quarter from $1.6 million in Q1 2017.
Nektar Therapeutics (NKTR) Capital Leases (2010 - 2017) Analysis & Trends
Nektar Therapeutics' Capital Leases history runs 8 years deep, the most recent figure standing at $1.1 million for Q2 2017.
- In Q2 2017, Capital Leases fell 61.68% year-over-year to $1.1 million; the TTM figure through Jun 2017 stood at $1.1 million (down 61.68% YoY), while the FY2016 annual figure was $2.2 million, up 107.18% from the prior year.
- Capital Leases for Q2 2017 stood at $1.1 million, down from $1.6 million in the prior quarter.
- The five-year high for Capital Leases was $10.8 million in Q1 2013, with the low at $1.1 million in Q2 2017.
- The 5-year median for Capital Leases is $3.7 million (2014), against an average of $4.6 million.
- The sharpest annual moves came in 2015 and 2016: Capital Leases sank 75.0% in 2015, then surged 107.18% in 2016.
- Nektar Therapeutics' Capital Leases stood at $8.0 million in 2013, then slumped by 48.58% to $4.1 million in 2014, then sank by 74.08% to $1.1 million in 2015, then soared by 107.18% to $2.2 million in 2016, then sank by 52.5% to $1.1 million in 2017.
- Business Quant data shows NKTR's Capital Leases at $1.1 million in Q2 2017, $1.6 million in Q1 2017, and $2.2 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Nektar Therapeutics | 1.49 Bn | 919.46 Mn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 1.06 Mn |
| Mar 31, 2017 | 1.61 Mn |
| Dec 31, 2016 | 2.22 Mn |
| Sep 30, 2016 | 2.14 Mn |
| Jun 30, 2016 | 2.76 Mn |
| Mar 31, 2016 | 3.33 Mn |
| Dec 31, 2015 | 1.07 Mn |
| Sep 30, 2015 | 1.34 Mn |
| Jun 30, 2015 | 2.89 Mn |
| Mar 31, 2015 | 4.39 Mn |
| Dec 31, 2014 | 4.14 Mn |
| Sep 30, 2014 | 5.34 Mn |
| Jun 30, 2014 | 6.03 Mn |
| Mar 31, 2014 | 7.05 Mn |
| Dec 31, 2013 | 8.05 Mn |
| Sep 30, 2013 | 9.01 Mn |
| Jun 30, 2013 | 9.90 Mn |
| Mar 31, 2013 | 10.77 Mn |
| Dec 31, 2012 | 11.61 Mn |
| Sep 30, 2012 | 12.41 Mn |